Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$64,282,928
+$34,540,327 QoQ
Shares Held
487,953
+132.7% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$586,950
PutShares
4,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $163,878,430 across 40 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (39.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
487,953 | $64,282,928 | |
| 2 | VTRS |
Viatris Inc
|
2,273,599 | $30,716,322 | |
| 3 | ALKS |
Alkermes plc.
|
277,619 | $9,816,607 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
158,093 | $7,612,177 | |
| 5 | LQDA |
Liquidia Corp
|
161,689 | $6,102,142 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
167,580 | $5,047,509 | |
| 7 | PRGO |
PERRIGO Co plc
|
464,742 | $4,991,329 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
63,538 | $4,886,072 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,282,928 | 487,953 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,742,601 | 209,706 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,682,722 | 40,481 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,940,205 | 166,602 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $586,950 | 4,300 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $7,877,476 | 68,369 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $4,248,763 | 30,806 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,564,648 | 80,181 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,189,487 | 28,351 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,127,117 | 117,997 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $16,785,919 | 165,836 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,003,867 | 33,522 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,124,068 | 57,660 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,267,629 | 13,004 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $9,135,375 | 97,444 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,292,804 | 62,144 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,677,178 | 17,487 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,872,436 | 19,240 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $276,870 | 2,847 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $387,617 | 4,044 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,330,758 | 13,839 | Shares | Defined | 2020-11-16 | |
| 2020-03-31 | $2,740,173 | 31,660 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||